22 January 2016: promotion of Prescription Only Medicines by Galderma
Published 12 February 2016
© Crown copyright 2016
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/advertising-investigations-january-2016/22-january-2016-promotion-of-prescription-only-medicines-by-galderma
MHRA received an anonymous complaint about promotional material for a prescription only medicine (POM) shared on LinkedIn by a Galderma employee.
MHRA upheld the complaint. Galderma assured MHRA that the material was an individual error of judgement by the employee and that this had happened without Galderma’s knowledge or authority. They provided details of remedial action taken to ensure that all staff are aware of company policy on the use of social media.